Nx. Nguyen et al., Visual rehabilitation and intraocular pressure elevation due to immunological graft rejection following penetrating keratoplasty, KLIN MONATS, 218(7), 2001, pp. 492-497
Purpose: Endothelial graft rejection and intraocular pressure elevation are
the most common causes of graft failure following penetrating keratoplasty
(PK). Aim of this study was to evaluate the visual rehabilitation and the
development of intraocular pressure during and after graft rejection.
Patients and Methods: The study included 20 eyes of 20 patients (age 54.7 /- 19.8 years) with endothelial graft rejection, that fullfilled the follow
ing inclusion criteria 1) graft rejection was diagnosed and treated in our
department; 2) at least one year follow-up after graft rejection; 3) avascu
lar corneal pathology. The mean follow-up was 23 +/- 14 months. According t
o the type of surgical procedure patients were classified in PK only (n = 1
5, one after cataract extraction), PK combined with extracapsular cataract
extraction and intraocular lens (IOL) implantation (n = 1); PK combined wit
h secondary IOL-implantation or JOL-exchange (n = 4). Standardized complete
ophthalmological examinations were performed on a regular basis before, du
ring the acute graft rejection und then regularly in a defined examination
raster in an out-patient service with cornea specialization.
Results: The time interval between first symptom of 18 acute diffuse and 2
chronic focal graft rejection and start of treatment was 9 +/- 13 days. Bes
t-corrected visual acuity (CVA) was 0.6 +/- 0.2 before graft rejection and
decreased significantly at the time of diagnosis (0.2 +/- 0.2: p = 0,001).
Six weeks after graft rejection CVA was 0.5 +/- 0.2 and remained almost sta
ble until one year after rejection (0.6 +/- 0.3) in 16 patients with revers
ible graft rejection. Only 4 patients (20%) showed an irreversible graft fa
ilure requiring Re-PK. Intraocular pressure (IOP) was not elevated in 75% o
f the patients (n = 15) and did not need any antiglaucomatous treatment dur
ing and after the rejection phase. In 5 eyes (25%) (3 after PK combined wit
h anterior chamber IOL-explantation and secondary posterior chamber IOL-im
plantation; 1 with secondary pseudoexfoliation glaucoma and 1 steroidal res
ponder) IOP was elevated during graft rejection (26 +/- 7 mm Hg), but was c
ontrolled by intensive topical antiglaucomatous treatment.
Conclusion: Typically, the visual rehabilitation after graft rejection was
good if the clinical signs were diagnosed just in time and treated adequate
ly. There is no direct correlation between graft rejection and intraocular
pressure elevation. However, the development of intraocular pressure elevat
ion seems to be strongly associated with preexisting glaucoma, preexisting
anterior synechiae and/or simultaneous anterior chamber lens implant remova
l. A careful patient management after PK plays an important role to prevent
the development of irreversible graft failure due to graft rejection.